RxDoctor Payments Data

Kristine Starcevich

Adult Health · Merrillville, INNPI 1437326881

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 789 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,446, 2.3 times the $2,403 reported in 2021. Among adult health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,927in general payments, 2019–2025

Across 789 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • Jazz Pharmaceuticals Inc.$1K
  • AbbVie$1K
  • Novartis$1K
  • Avadel CNS Pharmaceuticals, LLC$980
  • Livanova USA, Inc.$784
  • plus $11K from 54 others

What the payments were for

  • Consulting fees$3502%
  • Food & beverage$18,43097%
  • Education$1471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen77$2,342
Jazz Pharmaceuticals Inc.55$1,455
AbbVie(2 entities)102$1,371
Novartis81$1,177
Avadel CNS Pharmaceuticals, LLC24$980
Livanova USA, Inc.13$784
Teva Pharmaceuticals USA, Inc.36$764
Johnson & Johnson(2 entities)21$595
Neurocrine Biosciences, Inc.10$588
Bristol Myers Squibb22$559
AstraZeneca14$532
Otsuka America Pharmaceutical, Inc.15$525
EMD Serono, Inc.12$494
Lilly USA, LLC22$477
Axsome Therapeutics, Inc.16$450
SK Life Science, Inc.21$421
Amgen12$410
Lundbeck LLC20$393
TG Therapeutics, Inc.13$391
Acadia Pharmaceuticals Inc19$365
Acorda Therapeutics, Inc19$356
UCB, Inc.15$330
Argenx US, Inc.13$263
Inspire Medical Systems, Inc.2$239
Pfizer17$208
Kyowa Kirin, Inc.3$197
Harmony Biosciences LLC9$177
Neurelis, Inc.5$171
Takeda Pharmaceuticals U.S.A., Inc.11$160
Merz Pharmaceuticals, LLC7$151
Catalyst Pharmaceuticals, Inc.8$143
Sanofi2$141
Merz North America, Inc.2$140
Corium, LLC6$124
Genentech USA, Inc.8$120
Banner Life Sciences, LLC6$101
Supernus Pharmaceuticals, Inc.4$64
Eisai Inc.3$61
Amneal Pharmaceuticals LLC4$57
Otsuka Pharmaceutical Development & Commercialization, Inc.2$51
Tanabe Pharma America, Inc.3$45
Springworks Therapeutics, Inc.2$44
Aucta Pharmaceuticals, Inc.2$44
Avion Pharmaceuticals2$43
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Bausch Health US, LLC3$37
Impel Pharmaceuticals LLC3$35
Adamas Pharmaceuticals, Inc.2$32
Scilex Pharmaceuticals Inc.2$30
Impel Pharmaceuticals Inc.2$28
E.r. Squibb & Sons, L.L.C.1$26
Biohaven Pharmaceuticals, Inc.2$23
ANI Pharmaceuticals, Inc.1$22
Cycle Pharmaceuticals Inc1$18
Merck1$17
Akcea Therapeutics, Inc.1$16
Tris Pharma Inc1$15
Cala Health, Inc.1$15
Ironshore Pharmaceuticals Inc.1$14
Ipsen Biopharmaceuticals, Inc1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,927 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana

Medicare billing

Part B allowed, 2024
$114,186
Medicare patients
410
Services billed
6,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate25$35,553
Emgality PenGalcanezumab-Gnlm26$33,756
SunosiSolriamfetol Hcl16$17,162
UbrelvyUbrogepant14$13,928
Lacosamide71$9,482
TegretolCarbamazepine13$7,958
Rasagiline Mesylate11$5,919
Tegretol XrCarbamazepine12$5,696
Rivastigmine19$5,032
DilantinPhenytoin Sodium Extended15$4,685
Pregabalin120$3,527
Oxcarbazepine33$3,441
Levetiracetam76$2,845
Gabapentin163$2,738
Carbamazepine ErCarbamazepine17$2,670

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt, Dilantin$208$40,23840 claims
Axsome Therapeutics, Inc.Sunosi$450$17,16216 claims
AbbVieUbrelvy$1,371$13,92814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 391 adult health providers in Indiana.

Other adult health in Merrillville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →